Venclose, a San Jose-based medical device company, just received $27 million in a Series C round led by the Ally Bridge Group. The funding will support the company’s efforts to market its radio ...
Chronic venous insufficiency (CVI) is one of those health conditions that quietly affects millions, yet many people don’t ...
12 month closure rates for the VenaSeal closure system comparable to radiofrequency ablation DUBLIN, Medtronic plc today announced the twelve-month results of the VeClose pivotal study, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results